Manuscript Summary - ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia
ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic TelangiectasiaPublished on June 8, 2023A new study from the lab of Dr. Stryder Meadows at Tulane University – Summarized by Adella Guidroz and Shreya Bavishi The General Question: Is elevated angiopoietin 2 (ANG2) in the endothelium a conserved feature in mouse models of HHT that can be
January 30, 2024